Prapaporn Pisitkun
Overview
Explore the profile of Prapaporn Pisitkun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piriyapongsa J, Chumnumwat S, Kaewprommal P, Triparn K, Suvichapanich S, Udomsinprasert W, et al.
Sci Rep
. 2024 Dec;
14(1):30683.
PMID: 39730427
Inter-individual variability in drug responses is significantly influenced by genetic factors, underscoring the importance of population-specific pharmacogenomic studies to optimize clinical outcomes. In this study, we analyzed whole genome sequencing...
2.
Jongkhajornpong P, Lekhanont K, Rattanasiri S, Pisitkun P, Thakkinstian A
Ophthalmol Ther
. 2024 Dec;
14(2):363-377.
PMID: 39704778
Introduction: The purpose of this study was to compare the growth factor concentrations in undiluted autologous platelet-rich plasma (APRP) and autologous serum (AS) eye drops. Methods: This was a single-center,...
3.
Wangriatisak K, de Vries C, Sharma R, Huang W, Gronwall C, Pisitkun P, et al.
Scand J Immunol
. 2024 Nov;
101(1):e13427.
PMID: 39592449
Altered composition of B-cell compartments is a known feature in patients with systemic lupus erythematosus (SLE). However, deep characterisation of B-cell subsets and their relation to clinical manifestations and disease...
4.
Munthananuchat P, Ngamjanyaporn P, Pisitkun P, Rotjanapan P
Clin Exp Med
. 2024 Oct;
24(1):241.
PMID: 39425800
Objective: Systemic lupus erythematosus (SLE) patients receiving immunosuppressive therapy are at risk for opportunistic infections (OIs), particularly Pneumocystis pneumonia (PCP). This study aimed to evaluate the effectiveness of trimethoprim/sulfamethoxazole (TMP/SMX)...
5.
Khunsri T, Thawornpan P, Tianpothong P, Suangtamai T, Ngamjanyaporn P, Leepiyasakulchai C, et al.
Arthritis Res Ther
. 2024 Sep;
26(1):159.
PMID: 39261963
Background: Systemic lupus erythematosus (SLE) is the quintessential autoimmune disease, as it is characterized by hyperactivity of CD4 T cells and subsequently drives lupus pathology. Follicular helper T (TFH) cells...
6.
Vejvisithsakul P, Thumarat C, Leelahavanichkul A, Hirankan N, Pisitkun T, Paludan S, et al.
Sci Rep
. 2024 Jun;
14(1):13968.
PMID: 38886451
The complexity of systemic lupus erythematosus (SLE) arises from intricate genetic and environmental interactions, with STING playing a pivotal role. This study aims to comprehend the function of STING using...
7.
Alee I, Chantawichitwong P, Leelahavanichkul A, Paludan S, Pisitkun T, Pisitkun P
Sci Rep
. 2024 May;
14(1):11020.
PMID: 38745067
The absence of stimulator of interferon genes (STING) in 129.B6.Fcgr2b-deficient mice rescue lupus phenotypes. The administration of a STING inhibitor (ISD017) into the young 129.B6.Fcgr2b-deficient mice prevents lupus nephritis development....
8.
Tangtanatakul P, Lei Y, Jaiwan K, Yang W, Boonbangyang M, Kunhapan P, et al.
Lupus Sci Med
. 2024 Mar;
11(1).
PMID: 38458775
Objectives: X chromosome has been considered as a risk factor for SLE, which is a prototype of autoimmune diseases with a significant sex difference (female:male ratio is around 9:1). Our...
9.
Jantaboon S, Sakunrangsit N, Toejing P, Leelahavanichkul A, Pisitkun P, Greenblatt M, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069267
Chronic inflammation contributes to the development of skeletal disorders in patients with systemic lupus erythematosus (SLE). Activation of the host immune response stimulates osteoclast activity, which in turn leads to...
10.
Temsangsukmanee J, Laisuan W, Thadanipon K, Pisitkun P, Ngamjanyaporn P, Suangtamai T, et al.
Sci Rep
. 2023 Sep;
13(1):14346.
PMID: 37658088
The anti-IFN-γ disease is a rare condition characterized by recurrent and persistent infections, potentially impacting the quality of life (QoL). However, comprehensive data on QoL in this population are lacking....